Blue Light Compromises Bacterial β‐Lactamases Activity to Overcome β‐Lactam Resistance
Lasers in Surgery and Medicine · 2024
DOI: 10.1002/lsm.23819 ↗Kurz gefasst
Fachartikel in der Zeitschrift Lasers in Surgery and Medicine, 2024. Verfasst von Carolina Dos Anjos und 8 weiteren Autor:innen. Beteiligte Einrichtung: Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: beta-Lactam Resistance, beta-Lactamases, Blue Light, Escherichia coli. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, This work was funded by the U.S. Department of Defense through the Military Medical Photonics Program (FA9550-20-1-0063) and the National Institute of Health (….
Abstract (Originalsprache)
Objective
In this study, we evaluated the effectiveness of antimicrobial blue light (aBL; 410 nm wavelength) against β‐lactamase‐carrying bacteria and the effect of aBL on the activity of β‐lactamases.
Methods
Pseudomonas aeruginosa , Escherichia coli , and Klebsiella pneumoniae strains carrying β‐lactamases as well as a purified β‐lactamase enzymes were studied. β‐lactamase activity was assessed using a chromogenic cephalosporin hydrolysis assay. Additionally, we evaluated the role of porphyrins in the photoreaction, as well as protein degradation by sodium dodecyl‐sulfate polyacrylamide gel electrophoresis (SDS‐PAGE). Finally, we investigated the bactericidal effect of combined aBL‐ceftazidime exposure against a metallo‐β‐lactamase expressing P. aeruginosa strain .
Results
Our study demonstrated that aBL effectively killed β‐lactamase‐producing bacteria and reduced β‐lactamase activity. After an aBL exposure of 1.52 J/cm 2 , a 50% reduction in enzymatic activity was observed in P. aeruginosa . Additionally, we found a 40% decrease in the photoreaction activity of porphyrins following an aBL exposure of 64.8 J/cm 2 . We also revealed that aBL reduced β‐lactamase activity via protein degradation (after 136.4 J/cm 2 ). Additionally, aBL markedly improved the bactericidal effect of ceftazidime (by >4‐log 10 ) in the metallo‐β‐lactamase P. aeruginosa strain.
Conclusion
Our results provide evidence that aBL compromises bacterial β‐lactamase activity, offering a potential approach to overcome β‐lactam resistance in bacteria.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
- Division of Infectious Diseases and Medical Services, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
- College of Engineering, University of Massachusetts, Amherst, Massachusetts, USA.
- Carnegie Mellon University, Pittsburgh, Pennsylvania, USA.
- Europa Point Campus, University of Gibraltar, Gibraltar, Gibraltar.
ORCID-Profile: Carolina Dos Anjos, Que Chi Truong-Bolduc, David C Hooper, R Rox Anderson, Tianhong Dai, Leon G Leanse
Förderung
- NIAID NIH HHS
- This work was funded by the U.S. Department of Defense through the Military Medical Photonics Program (FA9550-20-1-0063) and the National Institute of Health (…
Zitieren
APA
Dos Anjos, C., Wang, Y., Truong-Bolduc, Q. C., Bolduc, P. K., Liu, M., Hooper, D. C., Anderson, R. R., Dai, T., & Leanse, L. G. (2024). Blue Light Compromises Bacterial β‐Lactamases Activity to Overcome β‐Lactam Resistance. Lasers in Surgery and Medicine. https://doi.org/10.1002/lsm.23819
Vancouver
Dos Anjos C, Wang Y, Truong-Bolduc QC, Bolduc PK, Liu M, Hooper DC, et al. Blue Light Compromises Bacterial β‐Lactamases Activity to Overcome β‐Lactam Resistance. Lasers in Surgery and Medicine. 2024. doi:10.1002/lsm.23819
BibTeX
@article{DosAnjos2024,
author = {Dos Anjos, Carolina and Wang, Yin and Truong-Bolduc, Que Chi and Bolduc, Paul K and Liu, Matthew and Hooper, David C and Anderson, R Rox and Dai, Tianhong and Leanse, Leon G},
title = {Blue Light Compromises Bacterial β‐Lactamases Activity to Overcome β‐Lactam Resistance},
journal = {Lasers in Surgery and Medicine},
year = {2024},
doi = {10.1002/lsm.23819}
}
EUVIMED